Nexthera Capital’s Rocket Pharmaceuticals RCKT Stock Holding History

Nexthera Capital’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,500	Closed	-$476K	–	40
2015 Q4	$476K	Buy	+10,500	New	+$458K	0.68%	23

Other funds holding RCKT

DPA

Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Nexthera Capital's RCKT Position: Q1 2016 in Review

Nexthera Capital sold out of Rocket Pharmaceuticals (RCKT) in Q1 2016, closing a stake of 10,500 shares — an estimated $476K sold.

Nexthera Capital first reported a position in RCKT in Q4 2015 and held it in 1 quarter. The position peaked at $476K in Q4 2015. 58 funds tracked by Wall St. Rank hold RCKT as of Q1 2016.

Nexthera Capital reported no remaining Rocket Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Nexthera Capital sold 10,500 Rocket Pharmaceuticals shares in Q1 2016, an estimated $476K.
Nexthera Capital first reported a position in Rocket Pharmaceuticals in Q4 2015 and held it in 1 quarter.
Nexthera Capital's Rocket Pharmaceuticals position peaked at $476K in Q4 2015.
58 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2016.

Based on Nexthera Capital's 13F filing for Q1 2016, filed 13 May 2016.